The Matrix” and “Sense8” co-creator Lilly Wachowski has boarded “The Day Before,” an indie sci-fi short written, directed and starring Alexandra Grey. Grey leads an ensemble cast that includes Matthew ...

Eli Lilly said Thursday it will delay filing for FDA approval of its next-gen weight-loss drug, retatrutide, until the first quarter.

The risk of hair loss in patients taking GLP-1 drugs, while low, is higher than with other diabetes drugs, new studies suggest.

Has a wanted fugitive been posing as a biotech executive? And what does it take to develop a therapy for an ultra-rare ...

Eli Lilly LLY is a dominant player in the cardiometabolic market, backed by a strong and expanding GLP-1 portfolio. Its GLP-1 lineup includes Mounjaro and Zepbound (tirzepatide injections) for type II ...

Eli Lilly will seek regulatory approval for retatrutide, a powerful weight loss drug that a new study shows helped people lose nearly 56 pounds on average.

Eli Lilly (LLY +2.15%) has spent the past two years reinvesting the cash flow from its spectacularly successful GLP-1 drug into building out its pipeline, and it just made a diver ...

Eli Lilly & Co.’s highly anticipated next-generation weight-loss shot didn’t increase overall heart risk in a new study, the ...

Eli Lilly is preparing application materials for its next-generation weight-loss drug, retatrutide, following data from two ...

American Airlines said it is on course for an adjusted loss in the current quarter after the latest surge in jet fuel prices. Comcast Reports Lower Profit, Narrows Domestic Broadband-Subscriber Losses ...

A $2.5 billion settlement with Amazon Prime is in the works, a pharmaceutical company accuses another of false advertising ...

There are now positive results from five late-stage trials on retatrutide, which Lilly is positioning as the next pillar of ...